نتائج البحث

EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source (EMPA-ESUS)

• Authors : Addenbrookes Hospital, Cambridge

• Source: EMPA-ESUS. a Randomised Control Trial to Investigate the Impact of Empagliflozin on Left Atrial Function in Patients with Embolic Stroke of Undetermined Source

تفاصيل العنوان

Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD) (EMPA-PKD)

• Authors : Boehringer Ingelheim

• Source: Study of Empagliflozin in Patients with Autosomal Dominant Polycystic Kidney Disease (EMPA-PKD)

تفاصيل العنوان

Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity (EMPA)

• Authors : University of Missouri-Columbia

• Source: Arterial Destiffening Effects of SGLT2 Inhibition in Veterans With Obesity

تفاصيل العنوان

Effects of Acute and Chronic Empagliflozin Heart Failure (EMPA HF)

• Source: Renal Mechanistic Effects of Acute and Chronic Empagliflozin in Heart Failure

تفاصيل العنوان

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease (EMPA-PRED)

• Authors : Shin Kong Wu Ho-Su Memorial Hospital

• Source: The Safety and Efficacy of Empagliflozin in Patients With End-stage Renal Disease and Heart Failure With Preserved Ejection Fraction - a Randomized Controlled TrialGBD Chronic Kidney Disease

تفاصيل العنوان

Empagliflozin in Heart Failure with Reduced Ejection Fraction and End Stage Renal Disease (EMPA-RRED)

• Authors : Shin Kong Wu Ho-Su Memorial Hospital

• Source: The Safety and Efficacy of Empagliflozin in Patients with End-stage Renal Disease and Heart Failure with Reduced Ejection Fraction - a Randomized Controlled TrialRonco C, Haapio M, House AA,

تفاصيل العنوان

Empa PASS on Urinary Tract Malignancies

• Authors : Eli Lilly and Company

• Source: Post-authorisation Safety Study to Assess the Risk of Urinary Tract Malignancies in Relation to Empagliflozin Exposure in Patients With Type 2 Diabetes: a Multi-database European Study

تفاصيل العنوان

Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure (EMPA-AHF)

• Authors : Boehringer Ingelheim; Yuya Matsue, Associate Professor

• Source: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Empagliflozin in Patients With Acute Heart Failure

تفاصيل العنوان

Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease (EMPA-PD)

• Authors : Boehringer Ingelheim

• Source: Effect of Empagliflozin on Peritoneal and Kidney Function in End Stage Renal Disease

تفاصيل العنوان

EMPA-KIDNEY (The Study of Heart and Kidney Protection With Empagliflozin)

• Authors : Medical Research Council Population Health Research Unit, CTSU, University of Oxford (academic lead); Eli Lilly and Company

• Source: A Multicentre International Randomized Parallel Group Double-blind Placebo-controlled Clinical Trial of EMPAgliflozin Once Daily to Assess Cardio-renal Outcomes in Patients With Chronic KIDNEY

تفاصيل العنوان